We are live on ! Find out more
CAN

Cetera Advisor Networks Portfolio holdings

AUM $20.2B
1-Year Est. Return 22.31%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+22.31%
3 Year Est. Return
+28.92%
5 Year Est. Return
+81.68%
10 Year Est. Return
+158.85%
AUM
$12.3B
AUM Growth
+$4.29B
Cap. Flow
+$3.73B
Cap. Flow %
30.19%
Top 10 Hldgs %
13.98%
Holding
2,639
New
546
Increased
1,571
Reduced
364
Closed
91

Sector Composition

Rank Sector Weight
1 Technology 7.85%
2 Healthcare 5.01%
3 Financials 4.46%
4 Industrials 3.78%
5 Consumer Discretionary 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHF
2451
BNY Mellon High Yield Strategies Fund
DHF
$171M
$30K ﹤0.01%
13,901
+366
+3% +$810
WRAP icon
2452
Wrap Technologies
WRAP
$94.8M
$30K ﹤0.01%
17,731
-27,299
-61% -$49.6K
FCEL icon
2453
FuelCell Energy
FCEL
$1.7B
$29.5K ﹤0.01%
354
-99
-22% -$9.55K
FGH
2454
DELISTED
FG Group Holdings Inc.
FGH
$28.5K ﹤0.01%
10,866
GWH icon
2455
ESS Tech
GWH
$22.1M
$28.2K ﹤0.01%
772
+31
+4% +$1.59K
CRON
2456
Cronos Group
CRON
$1.05B
$27.1K ﹤0.01%
10,660
-1,403
-12% -$4.11K
NEUE
2457
DELISTED
NeueHealth
NEUE
$26.4K ﹤0.01%
509
+24
+5% +$1.74K
NNDM
2458
Nano Dimension
NNDM
$309M
$26.1K ﹤0.01%
+11,342
New +$27.6K
MNTS icon
2459
Momentus
MNTS
$88.7M
$24.4K ﹤0.01%
+3
New +$43.2K
NVTA
2460
DELISTED
Invitae Corporation
NVTA
$22K ﹤0.01%
+11,820
New +$28.9K
NYMX
2461
DELISTED
Nymox Pharmaceutical Corp
NYMX
$21.7K ﹤0.01%
67,125
+50,000
+292% +$18.1K
GOEV
2462
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$20.8K ﹤0.01%
+37
New +$22.7K
MBIO icon
2463
Mustang Bio
MBIO
$4.26M
$20.6K ﹤0.01%
70
FIRY
2464
Firy Inc
FIRY
$127M
$20.4K ﹤0.01%
2,015
-682
-25% -$12.5K
DNN icon
2465
Denison Mines
DNN
$2.63B
$20K ﹤0.01%
17,426
+2,968
+21% +$3.52K
PETV
2466
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
$19.6K ﹤0.01%
10,000
INO icon
2467
Inovio Pharmaceuticals
INO
$79.8M
$18.3K ﹤0.01%
+977
New +$22.1K
APPH
2468
DELISTED
AppHarvest, Inc. Common Stock
APPH
$17.6K ﹤0.01%
31,080
+3,800
+14% +$4.95K
VYNE icon
2469
VYNE Therapeutics
VYNE
$340K
$17.3K ﹤0.01%
6,389
PRTY
2470
DELISTED
Party City Holdco Inc.
PRTY
$16.8K ﹤0.01%
46,000
+25,000
+119% +$25.1K
SRNE
2471
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$15.7K ﹤0.01%
17,762
-7,118
-29% -$9.44K
ZOM
2472
DELISTED
Zomedica Corp.
ZOM
$14.8K ﹤0.01%
91,050
APTX
2473
DELISTED
Aptinyx Inc. Common Stock
APTX
$14.6K ﹤0.01%
51,000
+11,000
+28% +$3.18K
NVDA icon
2474
PUT
NVIDIA
NVDA
$5.01T
$13.9K ﹤0.01%
2,000
+1,000
+100% +$14.7K
VXRT
2475
DELISTED
Vaxart
VXRT
$13.6K ﹤0.01%
14,175
+3,875
+38% +$5.48K

Similar funds

Cetera Advisor Networks's Q4 2022 Portfolio in Review

As of Q4 2022, Cetera Advisor Networks held 2,639 positions worth $12.3B, up 53% from $8.05B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Cetera Advisor Networks deployed $3.73B of net new capital in Q4 2022, opening 546 new positions and adding to 1,571 existing holdings. Its largest new stake was iShares Treasury Floating Rate Bond ETF: 319,754 shares worth $16.1M.

By sector, the portfolio is most concentrated in Technology at 7.9% of assets, down from 8.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares 0-5 Year TIPS Bond ETF, an estimated $35.1M trimmed.

  • Cetera Advisor Networks's largest Q4 2022 buy was iShares Treasury Floating Rate Bond ETF: 319,754 shares worth $16.1M.
  • Cetera Advisor Networks added most to Vanguard Short-Term Bond ETF in Q4 2022, an estimated $120M increase.
  • Cetera Advisor Networks's biggest Q4 2022 reduction was iShares 0-5 Year TIPS Bond ETF, cutting an estimated $35.1M.
  • Cetera Advisor Networks fully exited Bluerock Residential Growth REIT, Inc. in Q4 2022, selling an estimated $3.17M.
  • Cetera Advisor Networks's ten largest holdings make up 14% of its $12.3B portfolio in Q4 2022.
  • Cetera Advisor Networks opened 546 new positions and closed 91 in Q4 2022.
  • Cetera Advisor Networks's portfolio value rose 53% quarter-over-quarter to $12.3B.

Based on Cetera Advisor Networks's 13F filing for Q4 2022, filed 14 Feb 2023.